The serum levels of CCL20, CXCL10, CCL2, IL-9, IL-21, and IL-17A were significantly higher in CRC patients than in HD (fold change ≥ 2, p < 0.05) (Fig. 2a). The gene discussed is CXCL10; the disease is colorectal carcinoma.